IDYA
Price
$37.35
Change
-$0.46 (-1.22%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
3.69B
39 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$10.65
Change
-$0.00 (-0.00%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
943.87M
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IDYA vs KURA

IDYA vs KURA Comparison Chart in %
View a ticker or compare two or three
VS
IDYA vs. KURA commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and KURA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
IDYA vs KURA: Fundamental Ratings
IDYA
KURA
OUTLOOK RATING
1..100
6271
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
64
Fair valued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
4354
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (31) in the null industry is somewhat better than the same rating for KURA (64) in the Biotechnology industry. This means that IDYA’s stock grew somewhat faster than KURA’s over the last 12 months.

IDYA's Profit vs Risk Rating (74) in the null industry is in the same range as KURA (100) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KURA’s over the last 12 months.

IDYA's SMR Rating (94) in the null industry is in the same range as KURA (99) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KURA’s over the last 12 months.

IDYA's Price Growth Rating (43) in the null industry is in the same range as KURA (54) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KURA’s over the last 12 months.

IDYA's P/E Growth Rating (100) in the null industry is in the same range as KURA (100) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYAKURA
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
74%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (IDYA: $37.81 vs. KURA: $10.65)
Brand notoriety: IDYA and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 84% vs. KURA: 115%
Market capitalization -- IDYA: $3.69B vs. KURA: $943.87M
IDYA [@Biotechnology] is valued at $3.69B. KURA’s [@Biotechnology] market capitalization is $943.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 1 FA rating(s) are green while KURA’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 3 TA indicator(s) are bullish while KURA’s TA Score has 3 bullish TA indicator(s).

  • IDYA’s TA Score: 3 bullish, 6 bearish.
  • KURA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than KURA.

Price Growth

IDYA (@Biotechnology) experienced а +2.91% price change this week, while KURA (@Biotechnology) price change was -1.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 10, 2026.

KURA is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IDYA
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TMSL41.060.36
+0.88%
T. Rowe Price Small-Mid Cap ETF (TMSL)
IBMR24.770.04
+0.16%
iShares iBonds Dec 2029 Term Muni Bond ETF (IBMR)
PJFG120.910.06
+0.05%
PGIM Jennison Focused Growth ETF (PJFG)
BAIG20.22N/A
N/A
Leverage Shares 2X Long Bbai Daily ETF
BAMY26.50-0.02
-0.08%
Brookstone Yield ETF (BAMY)

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with RNA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-1.59%
RNA - IDYA
48%
Loosely correlated
-1.69%
DYN - IDYA
45%
Loosely correlated
-1.80%
KURA - IDYA
45%
Loosely correlated
-0.56%
MLTX - IDYA
44%
Loosely correlated
-1.97%
RXRX - IDYA
43%
Loosely correlated
-1.45%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with IMVT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-0.56%
IMVT - KURA
53%
Loosely correlated
-0.38%
XNCR - KURA
52%
Loosely correlated
-0.72%
KYTX - KURA
49%
Loosely correlated
-4.12%
RLAY - KURA
48%
Loosely correlated
+2.44%
VIR - KURA
48%
Loosely correlated
+0.98%
More